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During early vertebrate development Fibroblast Growth Factor (FGF) signalling is required for multiple activities including specification of
mesodermal, neural and heart tissue, as well as gastrulation movements and regulation of differentiation and pattern onset in the extending body
axis. A current challenge is to understand how FGF signalling generates such diverse outcomes. A key FGF downstream pathway is the Ras-
MAPK/Erk1/2 cascade, which culminates in the phosphorylation of target proteins, such as the Ets family of transcription factors. To begin to
assess specificity downstream of FGF in the chick embryo we have characterised the patterns of Fgfr1–4 expression and Erk1/2 activation, as well
as expression of the Erk1/2 specific phosphatase, Mkp3 and of three Ets factor genes (Erm, Pea3 and Er81) from early blastula to the 10 somite
stage. We identify new sites of Fgfr expression and show that nearly all regions of Erk1/2 activity are within Fgfr expression domains and require
FGF signalling. Differences in intensity, duration, distribution and sub-cellular localisation of activated Erk1/2 are observed in distinct cell
populations within the embryo and during wound healing. With few exceptions, a tight correspondence between Erk1/2 activation and Mkp3
expression is found, while specific combinations of Ets factors are associated with distinct regions of Erk1/2 activation. These findings provide a
comprehensive spatial and temporal map of FGF/Erk1/2 activity during early chick development and identify region and tissue specific differences
in expression of Fgfrs as well as Erk1/2 phosphorylation and transcriptional targets which help to define response specificity.
© 2006 Elsevier Inc. All rights reserved.Keywords: FGF; ERK1/2; Erk1/2; Chick embryo; Mkp3; Ets genes; Syn-expressionIntroduction
Signalling via Fibroblast Growth Factors (FGFs) is one of the
most important activities in the early vertebrate embryo as its
loss leads to early embryonic lethality (reviewed by Bottcher
and Niehrs, 2005). In particular, FGFs are required across
species for induction of mesodermal and neural tissue as well as
maintenance and patterning of the endoderm (e.g. Amaya et al.,
1991; Arman et al., 1998; Bottcher and Niehrs, 2005; Delaune et
al., 2005; Deng et al., 1997; Feldman et al., 1995; Slack et al.,
1996; Storey et al., 1998; Streit et al., 2000; Sun et al., 1999;
Wilson et al., 2000). FGF activity also mediates morphogenetic
movements underlying gastrulation (Ciruna and Rossant, 2001;
Nutt et al., 2001; Sivak et al., 2005; Yang et al., 2002). Later
FGF signals provided by lateral endoderm then specify cardiac⁎ Corresponding author.
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doi:10.1016/j.ydbio.2006.10.014mesoderm (Alsan and Schultheiss, 2002). FGF signalling is
required for the generation of all caudal tissues (Amaya et al.,
1991; Griffin et al., 1995) and also plays a key role in regulating
their differentiation. Declining levels of FGF signalling in the
extending body axis create a differentiation wavefront which
determines onset of neuronal differentiation and patterning in
newly generated spinal cord (Diez del Corral et al., 2002; Diez
del Corral et al., 2003) and also positions somite boundaries and
is thus a crucial part of the mechanism underlying segmentation
of the vertebrate body (Dubrulle et al., 2001; reviewed in Diez
del Corral and Storey, 2004). FGF signalling additionally directs
rostro-caudal character of newly generated body tissue via
regulation of caudal Hox gene expression (Bel-Vialar et al.,
2002; Dasen et al., 2003; Liu et al., 2001) and functions as a cell
survival and patterning signal in the developing rostral nervous
system (e.g. Chi et al., 2003; Lee et al., 1997; Storm et al., 2003).
Obviously, these very diverse outcomes are context depen-
dent, with FGF signalling acting in a cellular environment
537J.S. Lunn et al. / Developmental Biology 302 (2007) 536–552defined by previous as well as current signalling activities.
Specificity downstream of FGF signalling is provided at
multiple levels within the pathway, beginning with specific
binding affinities of FGF ligands (1–23) (Ornitz and Itoh, 2001)
for their tyrosine kinase receptors (Fgfr1–4 and their isoforms
(Ornitz et al., 1996)). These can determine signalling strength
and which downstream signal transduction pathways are
activated (e.g. Umbhauer et al., 2000; Vainikka et al., 1994).
The transduction of FGF signals during embryogenesis has been
largely assessed with respect to three major pathways,
PI3Kinase, PLCγ and Erk1/2/MAPK (reviewed by Bottcher
and Niehrs, 2005) and it is clear that these pathways can work in
concert to mediate cell fate decisions, for example, PI3K and
Erk1/2 synergise to promote mesoderm induction in the frog
(Carballada et al., 2001) and to coordinate cell behaviour with
assignment of cell fate (Sivak et al., 2005). It is striking,
however, that FGF signalling is responsible for nearly all Erk1/2
activity in early frog, fish and mouse embryos (Christen and
Slack, 1999; Corson et al., 2003; Tsang et al., 2004) and in this
paper we focus on FGF/Erk1/2 signalling activity during early
development of the chick embryo.
On ligand binding Fgfrs dimerise and undergo auto-
phosphorylation and activation of intra-cellular tyrosine kinase
domains. This in turn leads to tyrosine phosphorylation of
docking proteins FRS2α/β, which recruit the adaptor protein
Grb2 and the protein tyrosine phosphatase Shp2 resulting in
formation of multiple Grb2/Sos complexes and subsequent
activation of the Ras/MAP kinase signalling pathway. This
final signalling cascade involves sequential phopsphorylation
and activation of MAPKKK (Raf), MAPKK (Mek) and
MAPK(Erk1/2) (reviewed in Eswarakumar et al., 2005). The
cellular response to Erk1/2 signalling is determined by the
strength, duration, pattern and location of Erk1/2 activity. In
the early frog embryo, high levels of Erk1/2 signalling
promote a mesodermal cell fate while lower levels elicit an
early neural cell state, suggesting that specific threshold levels
of Erk1/2 signalling determine cellular response in this context
(Delaune et al., 2005; reviewed by Stern, 2005). Another way
in which Erk1/2 signalling can bring about distinct outcomes
is if cells experience sustained or transient Erk1/2 activation.
Strikingly, both of these signalling modes have been shown in
vitro to drive differentiation or proliferation depending on
cellular context and this emphasises the importance of context
in determining the cellular response to Erk1/2 signalling
(Marshall, 1995). It may also be possible for Erk1/2 signalling
to adopt a more dynamic activity pattern, such as oscillations,
which could be created by the action of feedback antagonists
(Bhalla et al., 2002; Heinrich et al., 2002). Indeed, the
duration of Erk1/2 signalling can determine whether activated
Erk1/2 translocates to the nucleus or remains cytoplasmic
(Marshall, 1995) and hence, whether it interacts directly with
transcription factor targets.
A growing number of proteins have been shown to modulate
Erk1/2 signalling, including: Spred, FRS2α, Sproutys, Sef,
FLRTs and Mkp3 (Bottcher et al., 2004; Brunet et al., 1999;
Camps et al., 1998; Casci et al., 1999; Furthauer et al., 2001,
2002; Groom et al., 1996; Hanafusa et al., 2002; Kramer et al.,1999; Lax et al., 2002; Reich et al., 1999; Sivak et al., 2005;
Torii et al., 2004; Tsang et al., 2002; Wakioka et al., 2001).
Expression of many of these genes has been reported to be
induced by FGF signalling in embryos (Sproutys 1,2,4, Sef,
FLRTs and Mkp3) (Bottcher et al., 2004; Eblaghie et al., 2003;
Furthauer et al., 2001, 2002; Kawakami et al., 2003; Minowada
et al., 1999; Tsang et al., 2002) and these genes have therefore
been included in the FGF syn-expression group (reviewed by
Niehrs and Meinhardt, 2002; Tsang and Dawid, 2004).
Expression of Sproutys 1,2, FLRT and Mkp3 are also known
to be Erk1/2 dependent and so work as feedback antagonists of
such signalling. These antagonists act at different levels in the
pathway and in different sub-cellular compartments to modulate
its activity. In some instances this feedback can determine sub-
cellular localisation of Erk1/2 activity, e.g. Sef; (Torii et al.,
2004) and help to separate cellular responses to FGF signalling,
e.g. Sprouty and Spred (Sivak et al., 2005).
The FGF syn-expression group also includes members of the
Ets family of transcription factors, Pea3 and Erm (Raible and
Brand, 2001; Roehl and Nusslein-Volhard, 2001) and Er81
(Munchberg and Steinbeisser, 1999), which constitute the Pea3
sub-group of Ets genes (De Launoit et al., 1997; Sharrocks,
2001). These factors are not only transcriptional targets of FGF
signalling, but are also phosphorylated and thereby activated by
Erk1/2 (Janknecht, 1996; Janknecht et al., 1996; O'Hagan et al.,
1996). It has yet to be established whether other Ets genes, such
as Ets1 and Elk1, which are also Erk1/2 substrates are regulated
by FGF/Erk1/2 signalling in the embryo (Edmunds and
Mahadevan, 2004; Sharrocks, 2001). Expression patterns of
Pea3 family Ets genes have been described in the early embryos
of fish, frog and mouse embryos (Chen et al., 1999; Chotteau-
Lelievre et al., 2001; Munchberg et al., 1999; Raible and Brand,
2001; Roehl and Nusslein-Volhard, 2001). Strikingly, in the
Zebrafish embryo Pea3 and Erm are induced in a nested pattern
by a local source of Fgf8 (Roehl and Nusslein-Volhard, 2001).
This suggests that expression of these Ets genes depends on
threshold levels of FGF/Erk1/2 signalling and that different
combinations of Ets genes then help to mediate distinct cellular
responses.
Here we present a detailed spatial and temporal map of the
expression patterns of key components of the FGF signalling
pathway and of MAPK/Erk1/2 activity in the early chick
embryo from prestreak to the 10 somite stage, when the basic
body plan is established. We determine whether FGF
signalling is required for activation of Erk1/2 and the
expression of Mkp3 (the phosphatase also known as Pyst1
or in human Dusp6, which specifically dephosphorylates
Erk1/2) throughout the 10 somite embryo. We also assess
activation of Erk1/2 and Mkp3 following wounding of the
embryonic epiblast. The location and levels of Fgfrs1–4,
Mkp3 expression and pErk1/2 activity in the embryo are
compared with the expression of three key Ets genes (Erm,
Pea3 and Er81). Together these data help to define the
repertoire of FGF pathway genes associated with specific sites
of Erk1/2 activity and provide the foundation for a develop-
mental atlas of FGF/Erk1/2 syn-expression groups in the early
chick embryo.
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Whole mount in situ hybridisation
Whole mount in situ hybridisation was carried out using standard techniques
and a subset of embryos was subsequently photographed, embedded in agar and
cryo-sectioned at 15 μm. Plasmids were kindly provided for Fgfr1 (Cek1),
Fgfr2 (Cek3) Fgfr3 (Cek2) by E. Pasquale (Patstone et al., 1993), quail
sequence for FREK/Fgfr4 by C. Marcelle (Marcelle et al., 1994), Mkp3 by S.
Keyse (Eblaghie et al., 2003) and Ets genes Pea3, Erm and Er81 by J. Lin and T.
Jessell (Lin et al., 1998). Sense probe controls forMkp3, Erm, Pea3, Er81 in the
early embryo (HH10) are presented in supplementary Figures S1 and S2.
Immunocytochemistry
Embryos were fixed rapidly in ovo with cold 4% paraformaldehyde, dissected
and then pinned out in fix for 1–2 h at 4°C, washed in PBS (Phosphate Buffered
Saline) and dehydrated to 100% methanol and stored overnight at −20°C.
Embryos were then rehydrated to PBS, treated with 3% H2O2/PBS 2 h (RT),
washed in PBS/0.5% Tween20, incubated in block (PBS, 0.5% T20 (PBST), 5%
heat inactivated goat serum and 2% BSA) overnight and subsequently incubated
in rabbit antibody against dual phosphorylated (dp)Erk1/2 (1:50) (Cell Signalling
Tech; as in Corson et al., 2003) for 2–4 days at 4°C. Embryos were then washed
in PBST and re-blocked (30 min) and incubated with a biotinylated anti-rabbit
antibody (1:1000) (Jackson) overnight at 4°C. This was followed by extensive
PBSTwashes, re-incubation in block (as above) and incubation in StreptAvidin–
HRP conjugate (1:50) (Becton Dickinson) or StreptAvidin-Cy3 (1:4000)
(Jackson) overnight at 4°C. Following extensive PBS washes some embryos
then underwent a standard DAB (diaminobenzidine tetrahydrochloride) reaction
to reveal HRP labelled cells. Nuclei were visualised in Cy3-labelled embryos with
DAPI. Embryos were photographed in wholemount and cryo-sectioned at 15 μm
using standard procedures and then photographed again, using a Lieca DM
compound microscope with a NikonD1 camera.
This antibody against dpErk1/2 has been used by a number of groups to
detect activated Erk1/2 (see (Corson et al., 2003)). To confirm that our protocol
also specifically detected dpErk1/2 we ran a series of no primary controls (n=7
runs with 2–6 embryos each) in parallel with embryos exposed to the primary
antibody and although a diffuse brown background was observed following
exposure to DAB, we did not detect cellular labelling in the absence of the
primary antibody (see Supplementary Figure S1).
Treatment with inhibitors
Hamburger and Hamilton (HH)(Hamburger and Hamilton, 1951) stage 10
embryoswere prepared on Isoporemembrane 1.2μmfilters (Millipore RTTP01300)
and maintained in separate wells in a 4 well plate (Nunc 176740) in Leibovitz's L15
medium supplemented with 5% calf serum and then treated with DMSO, 60 μM
SU5402 or 20 μMPD184352 for 2 h at 37°C in 5% CO2. Embryos were then fixed
and processed for insitu hybridisation or immunocytochemistry as described above.
Western blots
Stage 10 embryos were grown on filters and exposed to inhibitors (as
described above) and these were then cut from the extra-embryonic membrane
and lysed on ice. Three embryos were pooled in 50 μl lysis buffer, homogenised
and 10 μg lysate run on a polyacrylamide gel, transferred to a PVDF membrane
and incubated with antibodies to phospho-ERK 1/2 antibody (Cell Signalling)
(1:1000) or MKP3 (gift of S. Keyse; 1:350) or for total loading, α-Tubulin
(Abcam). Detection was performed using HRP-conjugated secondary antibodies
and enhanced chemi-luminescence.
Wounding
Embryos of HH3 were placed in EC culture and a small wound was made in
the embryonic epiblast parallel with the primitive streak with a dissecting pin.
Embryos were then incubated for 2 h, fixed and processed as above for detection
of dpErk1/2 or Mkp3.Results
Analysis of Fgfr expression patterns
Although expression of Fgfrs1–3 has been described
previously from late primitive streak stages (Walshe and
Mason, 2000) we wished to establish which Fgf receptors
are present earlier prior to primitive streak formation and
neural induction. We also wanted to characterise the
expression pattern of Fgfr4 (previously reported for
Hamburger and Hamilton (HH)(Hamburger and Hamilton,
1951) stages 2–6 and HH14–26, using radioactive insitu
methods (Marcelle et al., 1994) and to compare this with
that of Fgfrs1–3 during the critical period when the body
plan is being established from Eyal-Giladi (EG)(Eyal-Giladi
and Kochav, 1975) stage X to HH10.
Fgfrs at pre- and early primitive streak stages (EG, X- HH3+)
In prestreak embryos of EG stage X and early streak (HH2)
Fgfr1 and Fgfr4 are expressed in similar domains throughout
the epiblast at low levels, while neither Fgfr2 nor Fgfr3 are
detected at these early stages (Figs. 1A–D1). By HH3 Fgfr1,
Fgfr2 and Fgfr4 are present in the neural plate (Figs. 1E–H2).
Fgfr1 is detected throughout this tissue and is strikingly absent
from the primitive streak (Figs. 1E–E2). In contrast, Fgfr4
expression is refined to the rostral-most embryonic epiblast,
including the rostral edge of the neural plate (Figs. 1H–H2).
Fgfr4 is also detected very weakly in the anterior primitive
streak/node, as reported previously (Marcelle et al., 1994).
Expression of Fgfr2 is present weakly within the neural plate
and is also detected in the underlying hypoblast (Figs. 1F, F1).
Fgfr3 transcripts are still not detected at HH3 (Fig. 1G).
Fgfrs at late primitive streak/gastrula stage (HH4+–5)
By HH4+/5 when the primitive streak is maximally
extended and prechordal mesoderm/notochord is just emerging
at its tip, all four receptors are expressed (Figs. 1I–L2). Fgfr1
appears highest in the neural plate and this domain is now
expanded caudally into epiblast adjacent to the primitive
streak, while a reduced level of transcripts is detected at the
midline above the emerging prechordal mesoderm/notochord.
Fgfr1 is the first and only receptor to be expressed within
the primitive streak and at these stages is present only in the
epiblast layer of this tissue (Figs. 1I–I2). Strong expression of
Fgfr2 is now also observed throughout the neural plate and
(like Fgfr1) is detected weakly at the ventral midline (Figs.
1J–J2). Fgfr1 and Fgfr2 also appear asymmetric in the
epiblast of the node at this stage (Figs. 1I2, J2). Fgfr2
continues to be expressed in the spreading hypoblast and
nicely marks this cell population as it is displaced to the
periphery of the embryo by emerging endoderm and
mesoderm (Fig. 1J). Fgfr3 is first detected at this time,
appearing diffusely in the neural plate (Figs. 1K–K2). At this
stage Fgfr4 is further refined to the rostral lateral edges of the
neural plate (Figs. 1L–L2).
Fig. 1. Expression patterns of Fgfrs1–4 from pre to late primitive streak stages. Embryos at EG, prestreak stage X express Fgfr1 and Fgfr4 in the epiblast layer: (A)
Fgfr1; (B) Fgfr2; (C) Fgfr3; (D) Fgfr4. By HH stage 3–3+embryos express Fgfrs1, 2 and 4: (E) Fgfr1; (F) Fgfr2; (G) Fgfr3; (H) Fgfr4. At HH4+–5 all four Fgfrs
are now expressed; (I) Fgfr1 is now present in the primitive streak as well as neural plate; (J) Fgfr2 in present in hypoblast and neural plate; (K) Fgfr3 and (L) Fgfr4,
are detected in neural plate and lateral epiblast. Black lines indicate level of transverse sections (TS) presented below each embryo. TSs are through the neural plate and
node. ep=epiblast; hy=hypoblast; np=neural plate; ps=primitive streak; hn=Hensen's node; pm=paraxial mesoderm.
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At these early somite stages Fgfr1 is detected throughout the
neural plate (with the exception of the ventral midline underlain
by notochord), the primitive streak, including Hensen's node
and the emerging caudal paraxial mesoderm (Figs. 2A–A2). Incontrast, Fgfr2 expression is restricted to the neural plate rostral
to the primitive streak and is weakly detected in forming
precardiac mesoderm/endoderm (Figs. 2B–B2). Fgfr3 is
similarly localised in the neuroepithelium, but is additionally
detected in segmenting paraxial mesoderm (Figs. 2C–C2).
Fgfr2 and r3 are also detected in the displaced hypoblast in
Fig. 2. Expression patterns of Fgfrs1–4 from headfold to 10 somite stages. At HH6–7 all four Fgfrs are expressed (A) Fgfr1; (B) Fgfr2; (C) Fgfr3; (D) Fgfr4. At HH8–8+ (E) Fgfr1; (F) Fgfr2; (G) Fgfr3; (H) Fgfr4. At
HH10–11 (I) Fgfr1; (J) Fgfr2; (K) Fgfr3; (L) Fgfr4 with TSs at HH6–7 and HH8–8+ are through rostral neural plate and the node; TSs at HH10 are through forebrain/rostral neural tube, hindbrain/heart, spinal cord/
somites and node. Abbreviations as in Fig. 1 and cpm=caudal paraxial mesoderm; pfb=presumptive forebrain; som=somite; fb=forebrain; hb=hindbrain; hrt=heart; sc=spinal cord; rpsm=rostral presomitic
mesoderm; ol=optic lobe; im=intermediate mesoderm.
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541J.S. Lunn et al. / Developmental Biology 302 (2007) 536–552extra-embryonic regions. Fgfr4 transcripts are detected at low
levels in neural plate rostral to the primitive streak and at even
weaker levels in forming somites and precardiac mesoderm/
endoderm (Figs. 2D–D2).
Fgfrs at early neurulation (HH8–8+)
At HH8–8+Fgfr1 continues to be expressed throughout the
neural tube, but is detected at different levels in distinct regions.
High Fgfr1 levels are present in the presumptive forebrain to
hindbrain (Fig. 2E), but lower levels are detected in the neural
tube flanked by somites and these rise again slightly in more
caudal neural tissue (Fig. 2E). Fgfr1 transcripts also continue to
be absent from the ventral midline (Fig. 2E). At this stage Fgfr1
expression is detected throughout primitive streak, in the
emerging paraxial mesoderm and at low levels in precardiac
mesoderm/endoderm (Figs. 2E–E2). In contrast, Fgfr2 expres-
sion is more restricted within the nervous system; it is detected
in an intermediate region of the dorso-ventral axis of the
presumptive caudal forebrain and midbrain (Figs. 2F, F1), is
weakly detected in the future rostral hindbrain, then appears in
the neural tube flanked by somites, fading caudally into the
caudal neural plate (Figs. 2F–F2). Fgfr2 also persists in
precardiac mesoderm/endoderm and displaced hypoblast
(Figs. 2F, F1). Fgfr3 is detected dorsally within the presumptive
forebrain–hindbrain and unlike the other Fgfrs is now
expressed in the ventral midline of the neural tube from the
forebrain to midbrain (Figs. 2G–G1). Fgfr3 is also uniquely
expressed in somites as well as in the adjacent neural tube at this
stage (Fig. 2G). Finally Fgfr4, is present in the dorsal neural
tube from forebrain to hindbrain regions of the CNS and is also
still detected weakly in the somites (Figs. 2H–H2).
Fgfrs at 10 somite stage (HH10)
Fgfr1 continues to be expressed throughout the neural tube
and regressing primitive streak. It is also detected in the
precardiac mesoderm and associated endoderm and at this stage
additional domains are now apparent in the ectoderm at the level
of the future otic vesicle, rostral presomitic mesoderm and
lateral plate mesoderm (Figs. 2I–I4). Within the neural tube
Fgfr2 is detected in the caudal forebrain and then in rostral
hindbrain and again in somite flanked neural tube (Figs. 2J–J2).
It is also present in precardiac mesoderm and strongly expressed
in the associated endoderm (Figs. 2J, J2, J3), but is absent from
the caudal neural plate (Fig. 2J4). Fgfr3 is expressed like r2 in
the caudal forebrain, then fades caudally, and appears again in
neural tube flanked by somites 1–4 but is then absent from more
caudal neural tissue (Figs. 2K, K1–K4). In contrast, the most
recently formed somites strongly express Fgfr3, as does the
adjacent intermediate mesoderm (Figs. 2K, K3). Fgfr2 and r3
transcripts also continue to be expressed in extra-embryonic
tissues (Figs. 2J, K). Fgfr4 is detected strongly in the rostral
forebrain and extends caudally within the neuroepithelium to
hindbrain levels. It is also expressed at low levels in precardiac
mesoderm/endoderm, in ectoderm in the region of the future
otic vesicle and in recently formed somites (Figs. 2L, L1–L4).Analysis of patterns of Erk1/2 activation and Mkp3 expression
FGF signalling can lead to phosphorylation and activation of
Erk1/2 in many contexts. We have demonstrated previously that
exposure to FGF stimulates Erk1/2 activity in the chick neural
plate (Eblaghie et al., 2003). Here, we therefore next wished to
assess the changing patterns of Erk1/2 activation during
development and to correlate these with expression profiles of
Fgfrs 1–4. This was carried out using an antibody that
recognises the dual phosphorylated form of Erk1/2. FGF
induced Erk1/2 signalling is required for expression of MAP-
Kinase phosphatase3 (Mkp3) in both chick neural plate and
limb bud mesenchyme (Eblaghie et al., 2003, and see
Kawakami et al., 2003; Tsang et al., 2004 Smith et al., 2006).
Mkp3 specifically dephosphorylates and inactivates Erk1/2
(Brunet et al., 1999; Camps et al., 2000; Groom et al., 1996) and
its dependence on FGF/Erk1/2 signalling constitutes a negative
feedback loop that serves to modulate Erk1/2 signalling. In
general, the pattern of Mkp3 expression shows a striking
coincidence with regions of Erk1/2 activation during these early
stages of development and we therefore present data for these
two components of the Erk1/2 pathway together.
Erk1/2 activation and Mkp3 at pre- and early primitive streak
stages (EG, X-HH3)
At prestreak stages dpErk1/2 and Mkp3 are detected at low
levels in the epiblast (Figs. 3A, B). DpErk1/2 is, however,
strongly detected in nuclei as well as the cytoplasm of cells at
the edge of the spreading blastodisc (Figs. 3C, D, E–E2). Mkp3
transcripts are also detected at low levels in a discrete domain at
the edge of the blastodisc (Fig. 3F). However, whether these
nuclear dpErk1/2 possessing cells co-express Mkp3, has yet to
be determined. At early streak stages (HH3) low level dpErk1/2
is now detected across the neural plate, with cells displaying
varying levels of activity suggestive of dynamic signalling. The
dpErk1/2 is also detected in the epiblast layer of the early
primitive streak (Figs. 3G, G1–G3) where mitotic cells revealed
by DAPI staining have elevated levels (Figs. 3H–H2). In
contrast, Mkp3 is restricted to the forming neural plate and
transcripts are strikingly absent from the primitive streak (Figs.
3I, I1, I2, I3). This is one of only a few embryonic tissues in
which we do not find a correspondence between Erk1/2 activity
and Mkp3 expression.
It has been previously shown that wounding leads to
activation of Erk1/2 in frog and mouse embryos (Christen and
Slack, 1999; Corson et al., 2003). Some data in the frog shows
that this Erk1/2 activity is FGF independent (Christen and
Slack, 1999) and so we wished to ascertain whether Mkp3
expression, which is FGF dependent, is associated with
wounding in the chick epiblast. Erk1/2 activation in response
to wounding is detected in the nucleus (Corson et al., 2003) and
so this approach might also help to confirm that our detection
methods are able to reveal nuclear labelling. Wounding the
epiblast at the lateral edge of the neural plate at HH3 led to local
accumulation of dpErk1/2 in both nucleus and cytoplasm,
without concomitant induction ofMkp3 (5/5 cases) (Figs. 3J, K,
Fig. 3. Erk1/2 activity andMkp3 expression patterns in pre- and early primitive streak embryos and during wound healing. (A), DpErk1/2 and (B),Mkp3 are detected
at low levels in the prestreak epiblast. DpErk1/2 is located in the nucleus and cytoplasm of cells at the edge of spreading blastodisc (C, D, E, E1) (DAPI) and (E2)
(DpErk/DAPI merged) (black outlined box in panel C indicates panel D, white arrowheads indicate nuclear DpErk) along with (F),Mkp3. DpErk1/2 is detected in the
presumptive neural plate and primitive streak at HH3, (G), and TSs (G1, G2, G3, H, H1)(DAPI), (H2) (DpErk/DAPI merged), white arrowheads indicate dpErk1/2
positive cells with DAPI labelled mitotic figures, black outlined box in panel G2 indicates panel G3. Mkp3 at HH3 (I) and TSs (I1,I2, I3) black outlined box in panel I2
indicates panel I3. Location of wound (red) in HH3 embryo (J). DpErk1/2, (K, K1) and Mkp3 (L, L1) following wounding. Abbreviations as in Fig. 1.
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lateral edge of the wound and is absent on the side abutted by
Mkp3 expressing neural plate (Figs. 3K1, L1).
Erk1/2 activation and Mkp3 at late primitive streak/gastrula
stage (HH4+)
By HH4+ a gradient of Erk1/2 activation is apparent across
the neural plate; high levels are detected at the ventral midline
and node and decline laterally (Figs. 4A, A1–A4). A similar
pattern of Mkp3 expression is seen in the neural plate at this
stage (Figs. 4B, B1–B4). DpErk1/2 andMkp3 are now also both
present at low levels in the epiblast layer of the primitive streak
(Figs. 4A3, A4; B3, B4).Erk1/2 activation and Mkp3 at headfold stages (HH5–6)
By HH5–6 dpErk1/2 activation and Mkp3 levels decline in
the neural plate, but high levels remain at the ventral midline
(Figs. 4C, C1, C2; D, D1–D4). Laterally both are detected in the
precardiac mesoderm and associated underlying endoderm
(Figs. 4C2, D2). High levels of dpErk1/2 and Mkp3 are now
detected in the node, primitive streak and its flanking epiblast.
At these stages dpErk1/2 and Mkp3 still exhibit left–right
asymmetry in the node, with high levels on the right hand side.
Within the primitive streak dpErk1/2 and Mkp3 are clearly
present in epiblast cells but Mkp3 transcripts are additionally
detected in emerging paraxial mesoderm, which exhibits little
Erk1/2 activity (Figs. 4C3, C4).
Fig. 4. Erk1/2 activity and Mkp3 expression patterns from late primitive streak to 10 somite embryos. At HH4+ dpErk1/2, (A) and TSs (A1) (rostral neural plate, laterally precardic mesoderm and endoderm), (A2)
(headprocess/notochord and neural plate), (A3) (node), (A4) (primitive streak, presomitic mesoderm) andMkp3, (B) and TSs through the same region as in panel A, (B1, B2, B3, B4). At HH5–6 dpErk1/2, (C) and TSs (C1,
C2, C3, C4) andMkp3(D), and TSs (D1, D2, D3, D4) (TS levels as in panel A). At HH7+ dpErk1/2 (E), and TSs (E1,E2, E3, E4) andMkp3 (F), and TSs (F1, F2, F3, F4) (TS levels as in panel A). At HH8–8+ dpErk1/2 (G) and
TSs (G1) (forebrain), (G2) (hindbrain, laterally precardic mesoderm and endoderm), (G3) (node), (G4) (primitive streak, presomitic mesoderm) and Mkp3, (H), and TSs (H1, H2, H3, H4) (TS levels as in panel G). At
HH9+10-, dpErk1/2 (I), and TSs (I1) (forebrain), (I2) (isthmus/midbrain/hindbrain border, heart), (I3) (spinal cord, somites, intermediate mesoderm), (I4) (node), (I5) (primitive streak, caudal presomitic mesoderm) and
Mkp3 (J), and TSs (J1, J2, J3, J4, J5) (TS levels as in panel I). Abbreviations as in Figs. 1 and 2 and hp/not=head process/notochord; vml=ventral midline; mb/is=midbrain/isthmus.
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At HH7+ dpErk1/2 and Mkp3 are now strongly detected in
the dorsal neural folds of the prospective forebrain, in the
ventral midline/floorplate throughout the neural axis and in
precardiac mesoderm and endoderm (Figs. 4E, F; E1, F1).Mkp3
is also expressed at high levels in the prospective caudal
hindbrain, while dpErk1/2 is weakly detected here and at the
lateral edges of the neural plate (Figs. 4E, F; E2, F2). Both
dpErk1/2 and Mkp3 are detected asymmetrically in the node
(Figs. 4E, F; E3, F3). Within the primitive streak, dpErk1/2 is
detected most robustly in the epiblast layer, while strong Mkp3
expression persists in the emerging presomitic mesoderm (Figs.
4E, F; E4, F4).
Erk1/2 activation and Mkp3 in early neurulation stages
(HH8–8+)
By HH8 the prospective forebrain has extended rostrally and
its lateral border is no longer underlain by precardiac
mesoderm/associated endoderm (Figs. 4G, H). At this stage
dpErk1/2 and Mkp3 are both detected in the forebrain, dorsally
and at the ventral midline, as well as in the underlying foregut
(Figs. 4G1, H1). At the level of the hindbrain Mkp3 and
dpErk1/2 are present in the neuroepithelium, the notochord, the
caudally displaced precardiac mesoderm, the first formed
somite(s) and the adjacent ectoderm (Figs. 4G2, H2). A gap in
Erk1/2 activity and Mkp3 expression then appears in the
embryo caudal to this level and both are then detected again in
the caudally extending body axis in the primitive streak,
adjacent epiblast/caudal neural plate and caudal paraxial
mesoderm (Figs. 4G, G3,4; H, H3,4).
Erk1/2 activation and Mkp3 at the 10 somite stage (HH10)
Many of the domains of activated Erk1/2 and Mkp3
described above have been refined by the 10 somite stage and
some new sites of detection are apparent (Figs. 4I, J).
DpErk1/2 and Mkp3 are both found in the rostral forebrain
(Figs. 4I1, 4J1). DpErk1/2 is also present in a dorsal to ventral
gradient in the forming isthmus at the junction of the
midbrain/hindbrain (4I2, 4J2). Mkp3 appears more uniform in
this region, but this may reflect a requirement for a more
precise comparison in the same embryo (Figs. 4I2, J2).
DpErk1/2 and Mkp3 are both expressed at a low level in the
vicinity of caudal hindbrain; a region overlying the develop-
ing heart in which they are also detected (Figs. 4I, J; I2, J2).
DpErk1/2 and Mkp3 continue to be conspicuously absent
from the body axis at the level of the somites, but are
detected caudal to this in the open neural folds, intermediate
mesoderm, caudal notochord, caudal neural plate and
primitive streak (Figs. 4I3–I5 and 4J3–J5). Caudal paraxial
mesoderm emerging from the streak still has lower levels of
dpErk1/2 than Mkp3 (Figs. 4I5, J5). Low level dpErk1/2 and
Mkp3 are also now apparent in medial rostral presomitic
mesoderm and in lateral plate mesoderm at the level of the
future forelimb bud (Figs. 4I, I5; J, J5).FGF signalling is required for most Erk1/2 activity and Mkp3
expression in the early chick embryo
To assess whether dpErk1/2 and Mkp3 in embryonic tissue
reflect activation via the FGF signalling pathway we cultured
HH10 embryos in the presence of the FGF receptor inhibitor
SU5402 for 2 h and compared both dpErk1/2 and Mkp3 levels
with control DMSO only treated embryos. In all cases (n=5) we
found a reduction in dpErk1/2 in key sites, including dorsal
forebrain, isthmus, developing heart and all caudal tissues in
SU5402 exposed embryos compared with untreated controls
(n=5)(Figs. 5A, B). A similar attenuation was also observed in
Mkp3 expression (n=9 cases) compared with DMSO only
treated control embryos, although some transcripts are still
detected in lateral plate mesoderm which expresses very high
levels of Mkp3 (n=7; Figs. 5C, D).
We also assessed levels of Erk activity and MKP3 expression
in whole stage 10 chick embryos by Western blot. This shows
that total Erk activity is reduced when FGF signalling is blocked
for 2 h, while MKP3 levels decline dramatically (Fig. 5E). This
difference likely reflects Erk stimulation associated with an
FGF independent wounding response (Christen and Slack,
1999) induced when the embryo is cut out or detached from the
vitelline membrane in culture filter. When Erk signalling is
blocked with the MEK inhibitor PD184352, both Erk activity
and MKP3 levels are lost (Fig. 5E). Overall these findings
indicate that activation of the Erk1/2 signalling pathway in the
early chick is, as in the mouse embryo (Corson et al., 2003),
largely FGF dependent and in most tissues confirm the
regulatory relationship between FGF/Erk1/2 signalling and
Mkp3 expression (Eblaghie et al., 2003; Kawakami et al., 2003;
Smith et al., 2006; Tsang et al., 2004).
Analysis of Ets factor expression patterns
To reveal diversity in response to Erk1/2 signalling at
different times and in different tissues we next examined the
repertoire of Pea3 family Ets factors expressed during early
development.
Ets gene expression at pre- and early primitive streak stages
(EG, X- HH3+)
Only Pea3 expression is detected in prestreak embryos,
where it is localised in the epiblast layer (Figs. 6A–C1). Once
the streak has formed however, Erm and Pea3 are broadly
expressed in the epiblast which includes the neural plate (Figs.
6D, D1; E, E1). They are also detected in the primitive streak
(Figs. 6D2, E2), where they overlap with Er81 expression (Figs.
6F, F2).
Ets gene expression at late primitive streak/gastrula stage
(HH4+–5)
All three Ets genes are expressed at HH4+–5; Erm and Pea3
are expressed throughout the neural plate and primitive streak
and while Er81 is restricted to the primitive streak (Figs. 6G, H,
Fig. 5. FGF signalling is required for Erk1/2 activity andMkp3 expression throughout the 10 somite embryo. DpErk1/2 in embryos exposed to control DMSO (A) and
the FGF receptor antagonist SU5402 (B). Mkp3 in embryos exposed to control DMSO (C) and SU5402 (D). Western blots of whole HH10 embryos exposed to
DMSO, SU5402, PD184352, (E). Three separate experiments were carried out for western blotting, two of which are shown here.
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(Figs. 6G, G2), however, this region strongly expresses Pea3
and Er81 (Figs. 6H2, I2).
Ets gene expression at headfold/early segmentation (HH6–7)
As the notochord emerges from the primitive streak Erm, the
most widely expressed of these Ets genes, is found throughout
the neural plate with the exception of intermediate regions of the
rostral neural plate (Figs. 6J, J1). In contrast, Pea3 expression is
lost from this tissue except in the ventral midline (floor plate and
head process/notochord) (Figs. 6K, K1). Pea3 is also now
present in the prospective caudal hindbrain, somites, caudal
neural plate, precardiac mesoderm, emerging axial and
caudal paraxial mesoderm and the primitive streak (Fig. 6K, K1,
K2). Er81 expression is confined to the primitive streak,
where its levels of expression in the node are asymmetric
(Figs. 6L, L1, L2).
Ets gene expression at early neurulation stages (HH8–8+)
Erm and Pea3 are both expressed in the dorsal forebrain and
the prospective caudal hindbrain and precardiac mesoderm
(Figs. 6M, N; M1, N1), but Erm expression is present
throughout the neural axis to the level of the somites. Strikingly,
both Erm and Pea3 are then absent from neural tube flanked by
somites, although Pea3 continues to be expressed in somites
(Figs. 6M, N). In caudal regions both Erm and Pea3 are
expressed in the open neural folds, caudal neural plate and
primitive streak (Figs. 6M, N; M2, N2). Strikingly, both these
genes are also detected in the paraxial mesoderm but Pea3 is
expressed more strongly than Erm, while Er81 expression isconfined to the caudal neural plate and primitive streak (Figs.
6O, O1, O2).
Ets gene expression at 10 somite stage (HH10)
Erm continues to be expressed throughout the neural tube
rostral to the forming somites and in cardiac mesoderm (Figs.
6P, P1, P2). It is additionally detected in ectoderm at the level of
the future otic vesicle (Fig. 6P2) and at low level in recently
formed somites and intermediate mesoderm (Figs. 6P, P3). Erm
is then expressed extensively in caudal tissues, throughout
presomitic mesoderm, caudal neural tissue and the primitive
streak (Figs. 6P, P3, P4). Pea3 is present in rostral forebrain,
isthmus region of the midbrain/hindbrain, caudal hindbrain and
adjacent ectoderm as well as precardiac mesoderm, somites and
the intermediate mesoderm (Figs. 6Q, Q1–3). Pea3 is further
detected in rostral and caudal presomitic mesoderm as well as
caudal neural tissue and the primitive streak (Figs. 6Q, Q4).
Er81 is weakly expressed in the dorsal forebrain (Figs. 6R, R1)
and is detected in precardiac mesoderm (Fig. 6R, R2), lateral
plate mesoderm, caudal neural plate and the primitive streak
(Figs. 6R, R3–4).
Discussion
Key sites of Erk1/2 activation are characterised by distinct
repertoires of Fgfrs, Mkp3 and Ets factor expression
The repertoire of Fgfr, Mkp3 and Ets factor expression
patterns in key regions of Erk1/2 activation are summarised in
Fig. 7. These observations provide insight into the involvement
of Erk1/2 activity in early FGF mediated developmental
Fig. 6. Ets transcription factor expression patterns from prestreak to 10 somite embryos. Expression patterns of the Ets factors (A) Erm, (B) Pea3 and (C) Er81 at prestreak stages (all TSs through epiblast and hypoblast
layers). At HH3+–4 Erm (D) (TSs through (D1) neural plate and (D2) node), Pea3 (E), (E1, E2) (TSs as in panel D) and Er81(F, F1, F2) (TSs as in panel D) are all expressed. At HH4+–5 the nested expression of these Ets
genes is particularly apparent, Erm, (G, G1, G2); Pea3, (H, H1, H2), and Er81, (I, I1, I2). At HH6–7, Erm, (J, J1, J2) Pea3, (K, K1, K2), and Er81, (L, L1, L2) (all TSs as in panel D). At HH8–8+, Erm (M) (TSs through (M1)
hindbrain and (M2) primitive streak/caudal neural plate; Pea3 (N) (TSs through (N1) forebrain, precardic mesoderm and (N2) and primitive streak/caudal neural plate and Er81 (O) (TSs (O1) and (O2) as in panel M). At
HH10 Erm (P), TSs through (P1) (forebrain), (P2) (hindbrain, heart), (P3) (spinal cord, somites, intermediate mesoderm), (P4) (node); Pea3 (O, O1, O2, O3, O4) (TS levels as in pane P) and Er81, (R, R1, R2, R3, R4)
(primitive streak). Abbreviations as in Figs. 1 and 2.
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Fig. 7. Atlas of FGF/Erk1/2 activity and Fgfr, Ets factor and Mkp3 expression repertoires from early primitive streak to the 10 somite embryo. Summary of the main sites of Erk1/2 activity (DAB/brown labelling in
embryos, red in schematics) at key stages with associated repertoires of Fgfrs, Ets and Mkp3 expression.
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activation varies during the generation of different tissues. Here
we discuss these findings with respect to some key develop-
mental events.
Primitive streak cells give rise to the endodermal and
mesodermal layers of the embryo. A number of FGFs are
expressed in and around the early primitive streak (FGF2, Fgf3;
Fgf4; Fgf8) (Mahmood et al., 1995; Riese et al., 1995; Shamim
and Mason, 1999; Streit et al., 2000) and see (Karabagli et al.,
2002) and its formation depends on a combination of FGF,
Nodal and Chordin signalling (Bertocchini et al., 2004).
Strikingly, although dpErk1/2 and all three Ets factors are
detected in the early primitive streak we find that this is not
accompanied by expression of Fgfrs or Mkp3. This surprising
finding suggests that very low level Fgfr expression, an
unknown Fgfr or another pathway is responsible for this early
site of Erk activity. By late primitive streak stages Fgfr1 and
Mkp3 are now both present in this tissue and their appearance
coincides with the onset of cell movement through the primitive
streak as gastrulation commences.
Neural induction is initiated by FGF signalling in the chick
prior to gastrulation (Streit et al., 2000; Wilson et al., 2000) and
the detection of dpErk1/2 in the epiblast layer of prestreak
embryos where Fgfrs 1 and 4, Mkp3 and Pea3 are also
expressed, corresponds well with induction by FGF8 presented
by the underlying hypoblast (reviewed in Stern, 2005). By early
streak stages dpErk1/2 levels have increased in the neural plate
which now additionally expresses Fgfr2 and Erm. At this time
dpErk1/2 and Fgfr2 are also detected in the hypoblast
underlying the neural plate. Our data reveal that the neural
plate is a major site of dpErk1/2 activity. This then becomes
patterned as the axial mesoderm emerges beneath the neural
plate; dpErk1/2, Mkp3, Pea3 and Erm are now most strongly
detected in ventral and lateral (future dorsal) regions and at low
level in presumptive hindbrain region of the neural plate. As
development proceeds Erk activity becomes increasingly
restricted within the neuroepithelium with key sites in the
dorsal forebrain (with Fgfrs1,4, Mkp3, Erm and Pea3) and
isthmus region of the midbrain/hindbrain (with Fgfr1, 2,
(weakly r4) Mkp3, Erm and Pea3). Importantly, cells in the
caudal neural plate which progressively give rise to the caudal
hindbrain and spinal cord also continue to experience Erk1/2
activity and express Fgfr1, Mkp3, Erm, Pea3, and Er81.
The number of Fgfrs expressed in the neuroepithelium also
increases during development and distinct regions within this
tissue are characterised by specific combinations of these genes:
for example, in contrast to the caudal neural plate (above),
rostral-most neural plate (prospective forebrain) expresses all
four Fgfrs. Furthermore, expression of additional Fgfrs reflects
differentiation onset in the forming spinal cord at HH10. Here
undifferentiated cells in the caudal neural plate express Fgfr1,
but as cells leave this region and form the preneural tube (rostral
to the node) they express Fgfrs1 and 2. At the level of the
closed neural tube flanked by somites where neuronal
differentiation and ventral patterning commence (Diez del
Corral et al., 2002) Fgfrs 1,2, 3 (and eventually r4) are now
expressed.The establishment of left–right body axis in the embryo
commences in the node at HH5 (Levin et al., 1995). Fgf8 and
Fgf4 are asymmetrically expressed in the node at this time
(Boettger et al., 1999; Shamim and Mason, 1999) and Fgf8 has
been shown to be a key signalling molecule regulating left–
right asymmetry, determining the turning of the embryo and
positioning of the heart, gut and other visceral organs (Boettger
et al., 1999). Here we note that dpErk1/2 activity and Mkp3,
Fgfr1, Pea3 and Er81 are also asymmetrically localised in the
node at these stages, indicating that Erk1/2 signalling is likely to
mediate FGF8 activity in this context. Specification of cardiac
mesoderm is also mediated by FGF8, which is expressed by
endoderm underlying this presumptive cardiac tissue (Alsan
and Schultheiss, 2002). Here we identify this precardiac
mesoderm and associated endoderm as sites of active Erk
signalling that express Fgfrs 1, 2 (and weakly 4), Mkp3, Erm,
Pea3 and Er81.
The emergence of the paraxial mesoderm, which forms
somites that give rise to skeletal muscle, dermis and vertebrae,
commences at late primitive streak stages, at the time when
Fgfr1 is first detected in the streak. Although dpErk1/2 is
detected in the primitive streak at all stages, only low levels
were found in recently emerged caudal presomitic mesoderm,
consistent with the presence of only degrading Fgf8 transcripts
in this region (Dubrulle and Pourquie, 2004). However, as this
tissue expresses Mkp3 which is dependent on Erk1/2 activity, it
seems likely that such signalling is still active here. At HH10
there also appears to be a second peak of Erk activity andMkp3
expression in the rostral medial presomitic mesoderm which
may be associated with the raised levels of Fgfr1 in this tissue at
these later stages. Presomitic tissue also expresses a specific
combination of Ets factors; Erm is detected at low levels
throughout the presomitic mesoderm, Pea3 is expressed
strongly as this tissue first emerges from the primitive streak,
while Er81 is confined to the epiblast layer of the streak.
Importantly, Ets genes appear to be induced by different
thresholds of FGF signalling in the early zebrafish ectoderm
with Erm requiring a lower level than Pea3 (Roehl and
Nusslein-Volhard, 2001). This regulatory relationship correlates
well with the expression patterns and levels of these Pea3 family
Ets genes in the caudal presomitic mesoderm and also within the
developing nervous system, where Erm is more widely
expressed than Pea3, and Er81 transcripts are found in a subset
of regions with high Erk1/2 activity (see Fig. 7).
The relationship between FGF signalling and Erk1/2 activity
The detection pattern of dpErk1/2 coincides well with the
location of cell populations likely to be exposed to known
sources of FGF ligand and in particular Fgf8 (Karabagli et al.,
2002). We have shown previously that expression of Mkp3 in
the limb and early neural plate depends on FGF/Erk1/2
signalling (Eblaghie et al., 2003; Smith et al., 2006) and
demonstrate here a striking localisation of Mkp3 expression to
nearly all sites of dpErk1/2 activity in the early embryo. The
dependency of dpErk1/2 activation and Mkp3 expression on
FGF signalling is also demonstrated by their near complete loss
549J.S. Lunn et al. / Developmental Biology 302 (2007) 536–552when we block FGF signalling in 10 somite stage embryos. The
sites of FGF dependent Erk1/2 signalling identified here are the
same as those characterised in the 10 somite mouse embryo
(excluding the intermediate mesoderm and extra embryonic
tissues (Corson et al., 2003), indicating that this is a conserved
regulatory relationship.
As noted above, at very early stages there is an exception to
this regulatory relationship. The primitive streak is exposed to
FGFs, but does not express any of the Fgfrs examined in this
study or the FGF/Erk1/2 dependent geneMkp3. FGF dependent
Erk1/2 activation is characteristic of early primitive streak
equivalent tissue in Xenopus (Christen and Slack, 1999; Curran
and Grainger, 2000; Schohl and Fagotto, 2002) and Zebrafish
(Tsang et al., 2004) although little Erk1/2-activation is detected
in the early mouse primitive streak (Corson et al., 2003). In the
mouse, zebrafish and frog, Mkp3 is, however, expressed in the
primitive streak/equivalent tissue (Dickinson et al., 2002; Klock
and Herrmann, 2002; Mason et al., 1996; Tsang et al., 2004).
Although there must be differences in turn over rate of protein
and mRNA these discrepancies may reflect species specific
differences in the timing/extent of Erk1/2 activation in the early
primitive streak and the repertoire of FGF induced Erk1/2
antagonists deployed in this tissue (Tsang and Dawid, 2004).
Conversely, there are regions of the embryo in which FGF
receptors are expressed, but in which Erk1/2, Mkp3 and Ets
genes are not detected. These include the caudal forebrain at
HH10 and in particular, the neural tube flanked by somites,
which expresses Fgfrs1, 2 and 3, but lacks the latter set of
genes indicative of dpErk1/2 activation at these early stages.
Although other FGF downstream pathways could be active, this
observation may support the generalisation that restriction of
ligand, rather than receptor distribution controls pathway
activation during early development.
Distribution and dynamics of Erk1/2 activity
Graded dpErk1/2 levels are detected across the neural plate
with high medial levels falling away laterally at HH4+ and this
is mirrored by Mkp3 expression with both dpErk1/2 and Mkp3
becoming restricted to lateral and medial regions of the neural
plate by HH5–6. A similar gradient of activation is also
apparent in the caudal neural plate, with cells close to the
primitive streak possessing higher levels than more rostral tissue
and this is again reflected in the levels of Mkp3. Although a
gradient of dpErk1/2 is less apparent in the caudal paraxial
mesoderm, cells in the dorsal primitive streak have higher levels
of dpErk1/2, suggesting that activation declines as cells move
through and emerge from the streak. A graded decline in Erk
activity is also indicated by the gradual loss ofMkp3 transcripts
from caudal presomitic mesoderm and this is most evident at
HH10. Finally, in the presumptive isthmus region at the
midbrain/hindbrain boundary a gradient of dpErk1/2 is detected
from dorsal to ventral.
There are also cell populations in the embryo which
experience sustained dpErk1/2. These include the primitive
streak, caudal neural plate, cardiac mesoderm and prospective
dorsal forebrain. In contrast, some tissues clearly experiencetransient Erk1/2 activation; these include the early neural plate,
which has broad low level dpErk1/2 that is lost (as noted above
in a graded fashion) and cells that are displaced out of the caudal
neural plate and primitive streak into the newly differentiating
body axis. Sustained versus transient Erk activity has been
shown to regulate proliferation versus differentiation in several
contexts (Marshall, 1995). Interestingly, at these early stages of
chick embryogenesis dpErk1/2 was only detected in known
proliferating cell populations.
With the exception of the edge of the spreading blastodisc,
the closing wound and the dividing cells in the primitive
streak, all dpErk1/2 detected appeared to be localised in the
cytoplasm. The detection of nuclear dp-Erk1/2 in some sites
strongly suggests that this cytoplasmic labelling is an accurate
indication of the sub-cellular location of Erk signalling in
chick embryonic tissues. A similar observation has been made
in the mouse embryo (Corson et al., 2003), where it is
suggested that there may be low levels or fast turnover of
nuclear dpErk1/2, mediated by the presence of MKP1 and 2 in
the nucleus. Our data suggest that this may also be due to the
presence of MKP3 at these sites as this cytoplasmically
located phosphatase not only specifically binds to and
inactivates dpErk1/2 (and can thereby set the level of Erk
signalling) but can also anchor Erk2 in the cytoplasm and so
regulate the sub-cellular localisation of Erk activity (Karlsson
et al., 2004). This is consistent with the absence of Mkp3
expression at the wound edge and the early streak where we
detect nuclear as well as cytoplasmic dpErk1/2. Cell by cell
analysis of Mkp3 and dpErk1/2 localisation in cells at the edge
of the extra-embryonic epiblast is, however, required to
determine whether this regulatory relationship holds in all
cases. As noted by Corson and colleagues cytoplasmic Erk
targets include p90Rsk which then translocates to the nucleus
to regulate transcription of immediate early genes. Erk activity
is also linked to chromatin remodelling, with nuclear Erk1/2
substrates, MSK1 and 2, phosphorylating nucleosomal
proteins, while phosphorylation of the Ets factor Elk1
promotes association with histone acetyltransferases (HATs)
(Edmunds and Mahadevan, 2004). Inhibition of Erk1/2
signalling also blocks cell migration in many contexts and
Erk1/2 cytoplasmic phosphorylation targets include Integrin
and Myosin light chain Kinase (MLCK), Calpain, FAK and
Paxillin, which mediate membrane protrusions and focal
adhesion dynamics/turn over (reviewed in Huang et al.,
2004). Indeed, in the early chick embryo, Erk activity has
recently been shown to regulate cell movement in the
presomitic mesoderm (Delfini et al., 2005).
In conclusion, Erk1/2 activity can direct diverse cellular
processes, including proliferation/differentiation and cell move-
ments as well as specification of distinct cell fates and can act
via a range of mechanisms to alter gene transcription (Dailey et
al., 2005) in addition to regulation of the cytoskeleton. Here we
define key sites of Erk1/2 activity in the early chick embryo and
characterise them with respect to expression of FGF receptors,
Mkp3 and three Erk1/2 phosphorylation targets, Erm, Pea3 and
Er81. We demonstrate that Mkp3 expression is a good read out
of Erk1/2 activity in the early embryo and that almost all Erk1/2
550 J.S. Lunn et al. / Developmental Biology 302 (2007) 536–552activity and Mkp3 expression depends on FGF signalling at
these stages. Furthermore, the globally nested expression of the
Pea3 family of transcription factors correlates well with levels
of Erk1/2 activity. Together these data have allowed us to create
a spatial and temporal map of FGF/Erk1/2 syn-expression
groups, which can be used to help identify further members of
the regulatory networks that provide specificity downstream of
FGF/Erk1/2 signalling.
Acknowledgments
We are grateful to John Heath (University Birmingham) and
Judith Skinner (University of Oxford) with whom we began
examination of Fgfr expression patterns at primitive streak
stages and to Janice Aitken (Duncan of Jordonstone College of
Art, University of Dundee) for drawings of embryos in Fig. 7.
We thank Marios Stavridis, Isabel Olivera-Martinez and
Stephen Keyse for comments on the manuscript. JSL was
supported by a BBSRC studentship, KJF by an MRC student-
ship and PH and KGS by the MRC. KGS is an MRC Senior
Non-Clinical Research Fellow (G9900177).
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.ydbio.2006.10.014.
References
Alsan, B.H., Schultheiss, T.M., 2002. Regulation of avian cardiogenesis by Fgf8
signaling. Development 129, 1935–1943.
Amaya, E., Musci, T.J., Kirschner, M.W., 1991. Expression of a dominant-
negative mutant of the FGF receptor disrupts mesoderm formation in
Xenopus embryos. Cell 66, 257–270.
Arman, E., Haffner-Krausz, R., Chen, Y., Heath, J.K., Lonai, P., 1998. Targeted
disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for
FGF signaling in pregastrulation mammalian development. Proc. Natl.
Acad. Sci. U. S. A. 95, 5082–5087.
Bel-Vialar, S., Itasaki, N., Krumlauf, R., 2002. Initiating Hox gene expression:
in the early chick neural tube differential sensitivity to FGF and RA
signaling subdivides the HoxB genes in two distinct groups. Development
129, 5103–5115.
Bertocchini, F., Skromne, I., Wolpert, L., Stern, C.D., 2004. Determination of
embryonic polarity in a regulative system: evidence for endogenous
inhibitors acting sequentially during primitive streak formation in the
chick embryo. Development 131, 3381–3390.
Bhalla, U.S., Ram, P.T., Iyengar, R., 2002. MAP kinase phosphatase as a locus
of flexibility in a mitogen-activated protein kinase signaling network.
Science 297, 1018–1023.
Bottcher, R.T., Niehrs, C., 2005. Fibroblast growth factor signaling during early
vertebrate development. Endocr. Rev. 26, 63–77.
Boettger, T., Wittler, L., Kessel, M., 1999. FGF8 functions in the specification of
the right body side of the chick. Curr. Biol. 9, 277–280.
Bottcher, R.T., Pollet, N., Delius, H., Niehrs, C., 2004. The transmembrane
protein XFLRT3 forms a complex with FGF receptors and promotes FGF
signalling. Nat. Cell Biol. 6, 38–44.
Brunet, A., Roux, D., Lenormand, P., Dowd, S., Keyse, S., Pouyssegur, J., 1999.
Nuclear translocation of p42/p44 mitogen-activated protein kinase is
required for growth factor-induced gene expression and cell cycle entry.
EMBO J. 18, 664–674.
Camps, M., Nichols, A., Gillieron, C., Antonsson, B., Muda, M., Chabert, C.,
Boschert, U., Arkinstall, S., 1998. Catalytic activation of the phosphataseMKP-3 by ERK2 mitogen-activated protein kinase. Science 280,
1262–1265.
Camps, M., Nichols, A., Arkinstall, S., 2000. Dual specificity phosphatases: a
gene family for control of MAP kinase function. FASEB J. 14, 6–16.
Carballada, R., Yasuo, H., Lemaire, P., 2001. Phosphatidylinositol-3 kinase acts
in parallel to the ERK MAP kinase in the FGF pathway during Xenopus
mesoderm induction. Development 128, 35–44.
Casci, T., Vinos, J., Freeman, M., 1999. Sprouty, an intracellular inhibitor of Ras
signaling. Cell 96, 655–665.
Chen, Y., Hollemann, T., Grunz, H., Pieler, T., 1999. Characterization of the
Ets-type protein ER81 in Xenopus embryos. Mech. Dev. 80, 67–76.
Chi, C.L., Martinez, S., Wurst, W., Martin, G.R., 2003. The isthmic organizer
signal FGF8 is required for cell survival in the prospective midbrain and
cerebellum. Development 130, 2633–2644.
Chotteau-Lelievre, A., Dolle, P., Peronne, V., Coutte, L., de Launoit, Y.,
Desbiens, X., 2001. Expression patterns of the Ets transcription factors from
the PEA3 group during early stages of mouse development. Mech. Dev. 108,
191–195.
Christen, B., Slack, J.M., 1999. Spatial response to fibroblast growth factor
signalling in Xenopus embryos. Development 126, 119–125.
Ciruna, B., Rossant, J., 2001. FGF signalling regulates mesoderm cell fate
specification and morphogenetic movement at the primitive streak. Dev. Cell
1, 37–49.
Corson, L.B., Yamanaka, Y., Lai, K.M., Rossant, J., 2003. Spatial and temporal
patterns of ERK signaling during mouse embryogenesis. Development 130,
4527–4537.
Curran, K.L., Grainger, R.M., 2000. Expression of activated MAP kinase in
Xenopus laevis embryos: evaluating the roles of FGF and other signaling
pathways in early induction and patterning. Dev. Biol. 228, 41–56.
Dailey, L., Ambrosetti, D., Mansukhani, A., Basilico, C., 2005. Mechanisms
underlying differential responses to FGF signaling. Cytokine Growth Factor
Rev. 16, 233–247.
Dasen, J.S., Liu, J.P., Jessell, T.M., 2003. Motor neuron columnar fate imposed
by sequential phases of Hox-c activity. Nature 425, 926–933.
de Launoit, Y., Baert, J.L., Chotteau, A., Monte, D., Defossez, P.A., Coutte, L.,
Pelczar, H., Leenders, F., 1997. Structure–function relationships of the
PEA3 group of Ets-related transcription factors. Biochem. Mol. Med. 61,
127–135.
Delaune, E., Lemaire, P., Kodjabachian, L., 2005. Neural induction in Xenopus
requires early FGF signalling in addition to BMP inhibition. Development
132, 299–310.
Delfini, M.C., Dubrulle, J., Malapert, P., Chal, J., Pourquie, O., 2005. Control of
the segmentation process by graded MAPK/ERK activation in the chick
embryo. Proc. Natl. Acad. Sci. U. S. A. 102, 11343–11348.
Deng, C., Bedford, M., Li, C., Xu, X., Yang, X., Dunmore, J., Leder, P., 1997.
Fibroblast growth factor receptor-1 (FGFR-1) is essential for normal neural
tube and limb development. Dev. Biol. 185, 42–54.
Dickinson, R.J., Eblaghie, M.C., Keyse, S.M., Morriss-Kay, G.M., 2002.
Expression of the ERK-specific MAP kinase phosphatase PYST1/MKP3 in
mouse embryos during morphogenesis and early organogenesis. Mech. Dev.
113, 193–196.
Diez del Corral, R., Storey, K.G., 2004. Opposing FGF and retinoid pathways: a
signalling switch that controls differentiation and patterning onset in the
extending vertebrate body axis. Bioessays 26, 857–869.
Diez del Corral, R., Breitkreuz, D.N., Storey, K.G., 2002. Onset of neuronal
differentiation is regulated by paraxial mesoderm and requires attenuation of
FGF signalling. Development 129, 1681–1691.
Diez del Corral, R., Olivera-Martinez, I., Goriely, A., Gale, E., Maden, M.,
Storey, K., 2003. Opposing FGF and retinoid pathways control ventral
neural pattern, neuronal differentiation, and segmentation during body axis
extension. Neuron 40, 65–79.
Dubrulle, J., Pourquie, O., 2004. fgf8 mRNA decay establishes a gradient that
couples axial elongation to patterning in the vertebrate embryo. Nature 427,
419–422.
Dubrulle, J., McGrew, M.J., Pourquie, O., 2001. FGF signaling controls somite
boundary position and regulates segmentation clock control of spatiotem-
poral Hox gene activation. Cell 106, 219–232.
Eblaghie, M.C., Lunn, J.S., Dickinson, R.J., Munsterberg, A.E., Sanz-Ezquerro,
551J.S. Lunn et al. / Developmental Biology 302 (2007) 536–552J.J., Farrell, E.R., Mathers, J., Keyse, S.M., Storey, K., Tickle, C., 2003.
Negative feedback regulation of FGF signaling levels by Pyst1/MKP3 in
chick embryos. Curr. Biol. 13, 1009–1018.
Edmunds, J.W., Mahadevan, L.C., 2004. MAP kinases as structural adaptors and
enzymatic activators in transcription complexes. J. Cell Sci. 117,
3715–3723.
Eswarakumar, V.P., Lax, I., Schlessinger, J., 2005. Cellular signaling by
fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16,
139–149.
Eyal-Giladi, H., Kochav, S., 1975. From cleavage to primitive streak formation;
a complementary normal table and new look at the first stages of the
development of the chick. I. General morphology. Dev. Biol. 49, 321–337.
Feldman, B., Poueymirou, W., Papaioannou, V.E., DeChiara, T.M., Goldfarb,
M., 1995. Requirement of FGF-4 for postimplantation mouse development.
Science 267, 246–249.
Furthauer, M., Reifers, F., Brand, M., Thisse, B., Thisse, C., 2001. Sprouty4 acts
in vivo as a feedback-induced antagonist of FGF signaling in zebrafish.
Development 128, 2175–2186.
Furthauer, M., Lin, W., Ang, S.L., Thisse, B., Thisse, C., 2002. Sef is a
feedback-induced antagonist of Ras/MAPK-mediated FGF signalling. Nat.
Cell Biol. 4, 170–174.
Griffin, K., patient, R., Holder, N., 1995. Analysis of FGF function in normal
and no tail zebrafish embryos reveals separate mechanisms for formation of
the trunk and tail. Development 121, 2983–2994.
Groom, L.A., Sneddon, A.A., Alessi, D.R., Dowd, S., Keyse, S.M., 1996.
Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a
novel cytosolic dual-specificity phosphatase. EMBO J. 15, 3621–3632.
Hamburger, H., Hamilton, H.L., 1951. A series of normal stages in the
development of the chick embryo. J. Exp. Morphol. 88, 49–92.
Hanafusa, H., Torii, S., Yasunaga, T., Nishida, E., 2002. Sprouty1 and Sprouty2
provide a control mechanism for the Ras/MAPK signalling pathway. Nat.
Cell Biol. 4, 850–858.
Heinrich, R., Neel, B.G., Rapoport, T.A., 2002. Mathematical models of protein
kinase signal transduction. Mol. Cell 9, 957–970.
Huang, C., Jacobson, K., Schaller, M.D., 2004. MAP kinases and cell migration.
J. Cell Sci. 117, 4619–4628.
Janknecht, R., 1996. Analysis of the ERK-stimulated ETS transcription factor
ER81. Mol. Cell. Biol. 16, 1550–1556.
Janknecht, R., Monte, D., Baert, J.L., de Launoit, Y., 1996. The ETS-related
transcription factor ERM is a nuclear target of signaling cascades involving
MAPK and PKA. Oncogene 13, 1745–1754.
Karabagli, H., Karabagli, P., Ladher, R.K., Schoenwolf, G.C., 2002.
Comparison of the expression patterns of several fibroblast growth factors
during chick gastrulation and neurulation. Anat. Embryol. (Berl.) 205,
365–370.
Karlsson, M., Mathers, J., Dickinson, R.J., Mandl, M., Keyse, S.M., 2004. Both
nuclear-cytoplasmic shuttling of the dual specificity phosphatase MKP-3
and its ability to anchor MAP kinase in the cytoplasm are mediated by a
conserved nuclear export signal. J. Biol. Chem. 279, 41882–41891.
Kawakami, Y., Rodriguez-Leon, J., Koth, C.M., Buscher, D., Itoh, T., Raya, A.,
Ng, J.K., Esteban, C.R., Takahashi, S., Henrique, D., Schwarz, M.F.,
Asahara, H., Izpisua Belmonte, J.C., 2003. MKP3 mediates the cellular
response to FGF8 signalling in the vertebrate limb. Nat. Cell Biol. 5,
513–519.
Klock, A., Herrmann, B.G., 2002. Cloning and expression of the mouse dual-
specificity mitogen-activated protein (MAP) kinase phosphatase Mkp3
during mouse embryogenesis. Mech. Dev. 116, 243–247.
Kramer, S., Okabe, M., Hacohen, N., Krasnow, M.A., Hiromi, Y., 1999.
Sprouty: a common antagonist of FGF and EGF signaling pathways in
Drosophila. Development 126, 2515–2525.
Lax, I., Wong, A., Lamothe, B., Lee, A., Frost, A., Hawes, J., Schlessinger, J.,
2002. The docking protein FRS2alpha controls a MAP kinase-mediated
negative feedback mechanism for signaling by FGF receptors. Mol. Cell 10,
709–719.
Lee, S.M., Danielian, P.S., Fritzsch, B., McMahon, A.P., 1997. Evidence that
FGF8 signalling from the midbrain–hindbrain junction regulates growth and
polarity in the developing midbrain. Development 124, 959–969.
Levin, M., Johnson, R.L., Stern, C.D., Kuehn, M., Tabin, C., 1995. A molecularpathway determining left–right asymmetry in chick embryogenesis. Cell 82,
803–814.
Lin, J.H., Saito, T., Anderson, D.J., Lance Jones, C., Jessell, T.M., Arber, S.,
1998. Functionally related motor neuron pool and muscle sensory afferent
subtypes defined by coordinate ETS gene expression [see comments]. Cell
95, 393–407.
Liu, J.P., Laufer, E., Jessell, T.M., 2001. Assigning the positional identity of
spinal motor neurons: rostrocaudal patterning of Hox-c expression by FGFs,
Gdf11, and retinoids. Neuron 32, 997–1012.
Mahmood, R., Kiefer, P., Guthrie, S., Dickson, C., Mason, I., 1995. Multiple
roles for FGF-3 during cranial neural development in the chicken.
Development 121, 1399–1410.
Marcelle, C., Eichmann, A., Halevy, O., Breant, C., Le-Douarin, N.M., 1994.
Distinct developmental expression of a new avian fibroblast growth factor
receptor. Development 120, 683–694.
Marshall, C.J., 1995. Specificity of receptor tyrosine kinase signaling: transient
versus sustained extracellular signal-regulated kinase activation. Cell 80,
179–185.
Mason, C., Lake, M., Nebreda, A., Old, R., 1996. A novel MAP kinase
phosphatase is localised in the branchial arch region and tail tip of Xenopus
embryos and is inducible by retinoic acid. Mech. Dev. 55, 133–144.
Minowada, G., Jarvis, L.A., Chi, C.L., Neubuser, A., Sun, X., Hacohen, N.,
Krasnow, M.A., Martin, G.R., 1999. Vertebrate Sprouty genes are induced
by FGF signaling and can cause chondrodysplasia when overexpressed.
Development 126, 4465–4475.
Munchberg, S.R., Steinbeisser, H., 1999. The Xenopus Ets transcription factor
XER81 is a target of the FGF signaling pathway. Mech. Dev. 80, 53–65.
Munchberg, S.R., Ober, E.A., Steinbeisser, H., 1999. Expression of the Ets
transcription factors erm and pea3 in early zebrafish development. Mech.
Dev. 88, 233–236.
Niehrs, C., Meinhardt, H., 2002. Modular feedback. Nature 417, 35–36.
Nutt, S.L., Dingwell, K.S., Holt, C.E., Amaya, E., 2001. Xenopus Sprouty2
inhibits FGF-mediated gastrulation movements but does not affect
mesoderm induction and patterning. Genes Dev. 15, 1152–1166.
O'Hagan, R.C., Tozer, R.G., Symons, M., McCormick, F., Hassell, J.A., 1996.
The activity of the Ets transcription factor PEA3 is regulated by two distinct
MAPK cascades. Oncogene 13, 1323–1333.
Ornitz, D.M., Itoh, N., 2001. Fibroblast growth factors. Genome Biol. 2
REVIEWS3005.
Ornitz, D.M., Xu, J., Colvin, J.S., McEwen, D.G., MacArthur, C.A., Coulier, F.,
Gao, G., Goldfarb, M., 1996. Receptor specificity of the fibroblast growth
factor family. J. Biol. Chem. 271, 15292–15297.
Patstone, G., Pasquale, E.B., Maher, P.A., 1993. Different members of the
fibroblast growth factor receptor family are specific to distinct cell types in
the developing chicken embryo. Dev. Biol. 155, 107–123.
Raible, F., Brand, M., 2001. Tight transcriptional control of the ETS domain
factors Erm and Pea3 by Fgf signaling during early zebrafish development.
Mech. Dev. 107, 105–117.
Reich, A., Sapir, A., Shilo, B., 1999. Sprouty is a general inhibitor of receptor
tyrosine kinase signaling. Development 126, 4139–4147.
Riese, J., Zeller, R., Dono, R., 1995. Nucleo-cytoplasmic translocation and
secretion of fibroblast growth factor-2 during avian gastrulation. Mech. Dev.
49, 13–22.
Roehl, H., Nusslein-Volhard, C., 2001. Zebrafish pea3 and erm are general
targets of FGF8 signaling. Curr. Biol. 11, 503–507.
Schohl, A., Fagotto, F., 2002. Beta-catenin, MAPK and Smad signaling during
early Xenopus development. Development 129, 37–52.
Shamim, H., Mason, I., 1999. Expression of Fgf4 during early development of
the chick embryo. Mech. Dev. 85, 189–192.
Sharrocks, A.D., 2001. The ETS-domain transcription factor family. Nat. Rev.,
Mol. Cell Biol. 2, 827–837.
Sivak, J.M., Petersen, L.F., Amaya, E., 2005. FGF signal interpretation is
directed by Sprouty and Spred proteins during mesoderm formation. Dev.
Cell 8, 689–701.
Slack, J.M., Isaacs, H.V., Song, J., Durbin, L., Pownall, M.E., 1996. The role of
fibroblast growth factors in early Xenopus development. Biochem. Soc.
Symp. 62, 1–12.
Smith, T.G., Karlsson, M., Lunn, J.S., Eblaghie, M.C., Keenan, I.D., Farrell,
552 J.S. Lunn et al. / Developmental Biology 302 (2007) 536–552E.R., Tickle, C., Storey, K.G., Keyse, S.M., 2006. Negative feedback
predominates over cross-regulation to control Erk/MAPK activity in
response to FGF signalling in embyros. FEBS Lett. 580, 4242–4245.
Stern, C., 2005. Neural Induction: old problem, new findings, yet more
questions. Development 132, 2007–2021.
Storey, K.G., Goriely, A., Sargent, C.M., Brown, J.M., Burns, H.D., Abud, H.M.,
Heath, J.K., 1998. Early posterior neural tissue is induced by FGF in the chick
embryo. Development 125, 473–484.
Storm, E.E., Rubenstein, J.L., Martin, G.R., 2003. Dosage of Fgf8 determines
whether cell survival is positively or negatively regulated in the developing
forebrain. Proc. Natl. Acad. Sci. U. S. A. 100, 1757–1762.
Streit, A., Berliner, A.J., Papanayotou, C., Sirulnik, A., Stern, C.D., 2000.
Initiation of neural induction by FGF signalling before gastrulation. Nature
406, 74–78.
Sun, X., Meyers, E.N., Lewandoski, M., Martin, G.R., 1999. Targeted disruption
of Fgf8 causes failure of cell migration in the gastrulating mouse embryo.
Genes Dev. 13, 1834–1846.
Torii, S., Kusakabe, M., Yamamoto, T., Maekawa, M., Nishida, E., 2004. Sef is a
spatial regulator for Ras/MAP kinase signaling. Dev. Cell 7, 33–44.
Tsang, M., Dawid, I.B., 2004. Promotion and attenuation of FGF signaling
through the Ras–MAPK pathway. Sci. STKE 2004, pe17.
Tsang, M., Friesel, R., Kudoh, T., Dawid, I.B., 2002. Identification of Sef, a
novel modulator of FGF signalling. Nat. Cell Biol. 4, 165–169.Tsang, M., Maegawa, S., Kiang, A., Habas, R., Weinberg, E., Dawid, I.B., 2004.
A role for MKP3 in axial patterning of the zebrafish embryo. Development
131, 2769–2779.
Umbhauer, M., Penzo-Mendez, A., Clavilier, L., Boucaut, J., Riou, J., 2000.
Signaling specificities of fibroblast growth factor receptors in early Xenopus
embryo. J. Cell Sci. 113 (Pt. 16), 2865–2875.
Vainikka, S., Joukov, V., Wennstrom, S., Bergman, M., Pelicci, P.G.,
Alitalo, K., 1994. Signal transduction by fibroblast growth factor
receptor-4 (FGFR-4). Comparison with FGFR-1. J. Biol. Chem. 269,
18320–18326.
Wakioka, T., Sasaki, A., Kato, R., Shouda, T., Matsumoto, A., Miyoshi, K.,
Tsuneoka, M., Komiya, S., Baron, R., Yoshimura, A., 2001. Spred is a
Sprouty-related suppressor of Ras signalling. Nature 412, 647–651.
Walshe, J., Mason, I., 2000. Expression of FGFR1, FGFR2 and FGFR3
during early neural development in the chick embryo. Mech. Dev. 90,
103–110.
Wilson, S.I., Graziano, E., Harland, R., Jessell, T.M., Edlund, T., 2000. An early
requirement for FGF signalling in the acquisition of neural cell fate in the
chick embryo. Curr. Biol. 10, 421–429.
Yang, X., Dormann, D., Munsterberg, A.E., Weijer, C.J., 2002. Cell
movement patterns during gastrulation in the chick are controlled by
positive and negative chemotaxis mediated by FGF4 and FGF8. Dev. Cell
3, 425–437.
